ARTICLE | Company News
Plantacor, University of Texas M.D. Anderson Cancer Center deal
August 2, 2004 7:00 AM UTC
Plantacor received exclusive licenses to three preclinical cancer therapeutics from the university. They include liposomal formulations of plant extracts curcumin and emodin to treat cancers such as l...